## Abstract RASSF2 can bind directly to K‐Ras and function as a negative effector of __Ras__ protein. RASSF2A is the only isoform of __RASSF____2__ that contains CpG islands in its promoter and it has been reported to be inactivated by its promoter methylation in several human cancers. In the prese
Inactivation of 14-3-3 σ by promoter methylation correlates with metastasis in nasopharyngeal carcinoma
✍ Scribed by Bin Yi; Shuang-Xiang Tan; Can-E Tang; Wei-Guo Huang; Ai-Lan Cheng; Cui Li; Peng-Fei Zhang; Mao-Yu Li; Jian-Ling Li; Hong Yi; Fang Peng; Zhu-Chu Chen; Zhi-Qiang Xiao
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 343 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
14‐3‐3 σ, the downstream target of p53, is a negative regulator of cell cycle G2‐M phase checkpoint in response to DNA damage. Our previous comparative proteomics study showed that 14‐3‐3 σ was downregulated or lost in nasopharyngeal carcinoma (NPC) tissue compared with non‐cancerous nasopharyngeal epithelial tissue (NNET). In this study, we further investigated for the epigenetic mechanism of 14‐3‐3 σ inactivation. Methylation‐specific PCR showed 14‐3‐3 σ promoter methylation in 100% of analyzed NPC cell lines (4/4) but not in immortalized human nasopharyngeal epithelial cell line NP69. Treatment of the four NPC cell lines with the methyltransferase inhibitor 5‐aza‐2′‐dC resulted in the demethylation and upregulation of 14‐3‐3 σ. In tissues, 14‐3‐3 σ promoter methylation occurred at a higher frequency in NPC, 63/75 (84%), compared to adjacent NNET, 7/25 (28%), and fully methylated 14‐3‐3 σ promoter was detected in NPC but not in any of adjacent NNET. RT‐PCR, Western blotting, and immunohistochemistry showed that 14‐3‐3 σ expression was downregulated or lost in NPC with methylation, and there was a negative correlation between the expression levels and methylation statuses of 14‐3‐3 σ gene. In addition, the patients with methylated 14‐3‐3 σ presented a higher frequency of lymph node and distant metastasis, and an advanced clinical stage, and overexpression of 14‐3‐3 σ in NPC cell line 5‐8F with high metastatic potential was able to inhibit its in vitro invasive ability. Our data are the first to show that 14‐3‐3 σ is frequently inactivated by promoter methylation in NPC and this aberrant methylation correlates with lymph node and distant metastasis. J. Cell. Biochem. 106: 858–866, 2009. © 2009 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES